MAb therapy against the IFN-α/β receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden

动脉发生 医学 后肢 受体 心肌保护 炎症 药理学 心脏病学 缺血 癌症研究 内科学 免疫学
作者
Paul F. A. Teunissen,Marieke C.S. Boshuizen,Maurits R. Hollander,P. Stefan Biesbroek,Nina Willemijn van der Hoeven,Jan‐Quinten Mol,Marion J. Gijbels,Saskia van der Velden,Tineke C. T. M. van der Pouw Kraan,Anton J.G. Horrevoets,Menno P.J. de Winther,Niels van Royen
出处
期刊:Cardiovascular Research [Oxford University Press]
卷期号:107 (2): 255-266 被引量:23
标识
DOI:10.1093/cvr/cvv138
摘要

AIMS: IFN-beta (IFNβ) signalling is increased in patients with insufficient coronary collateral growth (i.e. arteriogenesis) and IFNβ hampers arteriogenesis in mice. A downside of most pro-arteriogenic agents investigated in the past has been their pro-atherosclerotic properties, rendering them unsuitable for therapeutic application. Interestingly, type I IFNs have also been identified as pro-atherosclerotic cytokines and IFNβ treatment increases plaque formation and accumulation of macrophages. We therefore hypothesized that mAb therapy to inhibit IFNβ signalling would stimulate arteriogenesis and simultaneously attenuate-rather than aggravate-atherosclerosis. METHODS AND RESULTS: In a murine hindlimb ischaemia model, atherosclerotic low-density lipoprotein receptor knockout (LDLR(-/-)) mice were treated during a 4-week period with blocking MAbs specific for mouse IFN-α/β receptor subunit 1 (IFNAR1) or murine IgG isotype as a control. The arteriogenic response was quantified using laser Doppler perfusion imaging (LDPI) as well as immunohistochemistry. Effects on atherosclerosis were determined by quantification of plaque area and analysis of plaque composition. Downstream targets of IFNβ were assessed by real-time PCR (RT-PCR) in the aortic arch. Hindlimb perfusion restoration after femoral artery ligation was improved in mice treated with anti-IFNAR1 compared with controls as assessed by LDPI. This was accompanied by a decrease in CXCL10 expression in the IFNAR1 MAb-treated group. Anti-IFNAR1 treatment reduced plaque apoptosis without affecting total plaque area or other general plaque composition parameters. Results were confirmed in a short-term model and in apolipoprotein E knockout (APOE)(-/-) mice. CONCLUSION: Monoclonal anti-IFNAR1 therapy during a 4-week treatment period stimulates collateral artery growth in mice and did not enhance atherosclerotic burden. This is the first reported successful strategy using MAbs to stimulate arteriogenesis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冰棍发布了新的文献求助10
刚刚
刚刚
1秒前
wangwang完成签到,获得积分20
2秒前
完美世界的应助被开朗的尔蝶采纳,获得10
2秒前
2秒前
高贵冰烟完成签到,获得积分10
2秒前
坏坏完成签到,获得积分10
3秒前
飞翔的完成签到,获得积分10
3秒前
hhh发布了新的文献求助30
3秒前
llee2005完成签到,获得积分10
4秒前
4秒前
名古邬发布了新的文献求助20
5秒前
阿猫发布了新的文献求助10
6秒前
fantasy的应助被kbyang采纳,获得10
6秒前
EmmmlXL完成签到 ,获得积分10
7秒前
7秒前
锖青发布了新的文献求助10
8秒前
cpm完成签到,获得积分10
8秒前
aaaamy完成签到,获得积分10
8秒前
8秒前
好眠哈密瓜完成签到 ,获得积分10
9秒前
今后的应助被冰棍采纳,获得10
9秒前
9秒前
wangyi完成签到,获得积分10
10秒前
长庚完成签到,获得积分10
10秒前
Mythic完成签到,获得积分10
11秒前
怕孤独的飞飞完成签到,获得积分10
11秒前
义气的银耳汤完成签到 ,获得积分10
12秒前
12秒前
wanci的应助被wlj采纳,获得10
12秒前
永恒完成签到 ,获得积分10
13秒前
13秒前
www发布了新的文献求助10
13秒前
14秒前
15秒前
共享精神的应助被SHL采纳,获得10
16秒前
Zzz完成签到,获得积分10
16秒前
JINYUBAO完成签到,获得积分10
16秒前
tianjing0307完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181460
求助须知:如何正确求助?哪些是违规求助? 9571362
关于积分的说明 21817839
捐赠科研通 7777938
什么是DOI,文献DOI怎么找? 3433494
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479550